Gut Oxygen Therapy for Ischemic-Hypoxic Bowel Disease
Recruiting
N/A
Interventional Study
Chronic Ischemic-Hypoxic Enteropathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 100 (estimated)
- Sponsor
- The Second Hospital of Nanjing Medical University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This single-center, double-blind, randomized, intra-individual crossover controlled study aims to investigate the efficacy and safety of intestinal oxygen therapy via a deep intestinal catheter as a targeted route for intestinal oxygen delivery in the treatment of ischemic-hypoxic enteropathy, and simultaneously to explore and verify the chronobiological differences. Data have been obtained from t…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Definite diagnosis of chronic heart failure or obstructive sleep apnea (OSA) with chronic hypoxia;
* Comorbid intestinal dysmotility (abdominal distension, constipation, diarrhea, or abdominal pain);
* Disease duration ≥1 month with poor response to conventional treatment;
* T…
Contacts